Citations (8)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Naveen Pemmaraju, Prithviraj Bose, Raajit Rampal, Aaron T. Gerds, Angela Fleischman & Srdan Verstovsek. (2023) Ten years after ruxolitinib approval for myelofibrosis: a review of clinical efficacy. Leukemia & Lymphoma 64:6, pages 1063-1081.
Read now
Read now
Jia Chen, Lijuan Pan, Shiqiang Qu, Tiejun Qin, Zhijian Xiao & Zefeng Xu. (2022) Intra-abdominal Streptococcus agalactiae infection associated with myelofibrosis treated with ruxolitinib: a case report of an atypical clinical presentation. Current Medical Research and Opinion 38:3, pages 371-374.
Read now
Read now
Articles from other publishers (6)
骏 杨. (2023) MPN-Related Mutations and JAK2 Inhibitor Therapy. Advances in Clinical Medicine 13:01, pages 238-245.
Crossref
Crossref
Monia Marchetti, Jon Salmanton-García, Shaimaa El-Ashwah, Luisa Verga, Federico Itri, Zdeněk Ráčil, Julio Dávila-Valls, Sonia Martín-Pérez, Jaap Van Doesum, Francesco Passamonti, Ghaith Abu-Zeinah, Francesca Farina, Alberto López-García, Giulia Dragonetti, Chiara Cattaneo, Maria Gomes Da Silva, Yavuz M. Bilgin, Pavel Žák, Verena Petzer, Andreas Glenthøj, Ildefonso Espigado, Caterina Buquicchio, Valentina Bonuomo, Lucia Prezioso, Stef Meers, Rafael Duarte, Rui Bergantim, Ozren Jaksic, Natasha Čolović, Ola Blennow, Martin Cernan, Martin Schönlein, Michail Samarkos, Maria Enza Mitra, Gabriele Magliano, Johan Maertens, Marie-Pierre Ledoux, Moraima Jiménez, Fatih Demirkan, Graham P. Collins, Alba Cabirta, Stefanie K. Gräfe, Anna Nordlander, Dominik Wolf, Elena Arellano, Raul Cordoba, Michaela Hanakova, Giovanni Paolo Maria Zambrotta, Raquel Nunes Rodrigues, Giulia Limberti, Francesco Marchesi, Oliver A. Cornely & Livio Pagano. (2023) Outcomes of SARS-CoV-2 infection in Ph-neg chronic myeloproliferative neoplasms: results from the EPICOVIDEHA registry. Therapeutic Advances in Hematology 14, pages 204062072311547.
Crossref
Crossref
Hiroshi Kobe, Shinya Yokoe & Tadashi Ishida. (2022)
Incidental diagnosis of pulmonary cryptococcosis by rebiopsy for epidermal growth factor receptor
T790M
mutation: A case report
. Thoracic Cancer 14:2, pages 210-213.
Crossref
Crossref
Huan Ge, Caolin Wang, Chaoquan Tian, Yanyan Diao, Wanqi Wang, Xiangyu Ma, Jian Zhang, Honglin Li, Zhenjiang Zhao & Lili Zhu. (2022) Efficacy of WWQ-131, a highly selective JAK2 inhibitor, in mouse models of myeloproliferative neoplasms. Biomedicine & Pharmacotherapy 156, pages 113884.
Crossref
Crossref
Michael Stephan Bader & Sara Christina Meyer. (2022) JAK2 in Myeloproliferative Neoplasms: Still a Protagonist. Pharmaceuticals 15:2, pages 160.
Crossref
Crossref
Elsemieke te Linde, Laura J. E. Boots, Laura G. M. Daenen, Moniek A. de Witte & Anke H. W. Bruns. (2022) High Incidence of Herpes Zoster in Patients Using Ruxolitinib for Myeloproliferative Neoplasms: Need for Prophylaxis. HemaSphere 6:11, pages e793.
Crossref
Crossref